Anti-GABARAPL2/GATE-16 antibody [EP4808]
- RabMAb
- Recombinant
- KO Validated
- What is this?
5
(4 Reviews)
|
(12 Publications)
Rabbit Recombinant Monoclonal GABARAPL2/GATE-16 antibody. Suitable for WB and reacts with Human, Mouse, Rat samples. Cited in 12 publications.
View Alternative Names
FLC3A, GEF2, GABARAPL2, Gamma-aminobutyric acid receptor-associated protein-like 2, GABA(A) receptor-associated protein-like 2, Ganglioside expression factor 2, General protein transport factor p16, Golgi-associated ATPase enhancer of 16 kDa, MAP1 light chain 3-related protein, GEF-2, GATE-16
- WB
Lab
Western blot - Anti-GABARAPL2/GATE-16 antibody [EP4808] (AB126607)
Lane 1 : Wild-type HAP1 cell lysate (20 μg)
Lane 2 : GABARAPL2 / GATE-16 knockout HAP1 cell lysate (20 μg)
Lane 3 : HeLa cell lysate (20 μg)
Lane 4 : Human tonsil lysate (20 μg)
Lanes 1 - 4 : Merged signal (red and green). Green - ab126607 observed at 15 kDa. Red - loading control, ab8245, observed at 37 kDa.
ab126607 was shown to specifically react with GABARAPL2 / GATE-16 when GABARAPL2 / GATE-16 knockout samples were used. Wild-type and GABARAPL2 / GATE-16 knockout samples were subjected to SDS-PAGE. ab126607 and ab8245 (loading control to GAPDH) were diluted 1/1000 and 1/10 000 respectively and incubated overnight at 4°C. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed (ab216776) secondary antibodies at 1/10 000 dilution for 1 h at room temperature before imaging.
All lanes:
Western blot - Anti-GABARAPL2/GATE-16 antibody [EP4808] (ab126607)
Predicted band size: 14 kDa
false
- WB
Unknown
Western blot - Anti-GABARAPL2/GATE-16 antibody [EP4808] (AB126607)
All lanes:
Western blot - Anti-GABARAPL2/GATE-16 antibody [EP4808] (ab126607) at 1/1000 dilution
Lane 1:
Human fetal brain tissue lysate at 10 µg
Lane 2:
Human heart tissue lysate at 10 µg
Lane 3:
HeLa cell lysate at 10 µg
Lane 4:
Human spleen tissue lysate at 10 µg
Secondary
All lanes:
Goat anti-Rabbit HRP at 1/2000 dilution
Predicted band size: 14 kDa
Observed band size: 14 kDa
false
- OI-RD Scanning
Unknown
OI-RD Scanning - Anti-GABARAPL2/GATE-16 antibody [EP4808] (AB126607)
We have systematically measured KD (the equilibrium dissociation constant between the antibody and its antigen), of more than 840 recombinant antibodies to assess not only their individual KD values but also to see the average affinity of antibody. Based on the comparison with published literature values for mouse monoclonal antibodies, Recombinant antibodies appear to be on average 1-2 order of magnitude higher affinity.
- WB
CiteAb
Western blot - Anti-GABARAPL2/GATE-16 antibody [EP4808] (AB126607)
Western Blotting using Anti-GABARAPL2/GATE-16 antibody [EP4808], ab126607. Publication image from Holdgaard, S. G. et al., 2019, Nat Commun, 31519908. Legend direct from paper.
PCM1 accumulation and mitotic abnormalities show GABARAP selectivity. a Immunoblot of U2OS cell extracts following depletion of LC3B, GABARAP and GABARAPL2 individually or in combination as indicated showing levels of PCM1. GAPDH is used as loading control. b Densitometric quantification of PCM1 levels relative to GAPDH, represented in (a). Columns represent the mean ± SD, n = 3, ns > 0.05, **P ≤ 0.01, ***P ≤ 0.001. Unpaired Student’s t-test, two-tailed. c Representative images of PCM1-stained CS in U2OS cells depleted of the denoted ATG8 proteins. d Representative images of mitotic abnormalities in U2OS cells stained for γ-tubulin, β-tubulin and Hoechst33342 following depletion of the denoted ATG8 proteins. e Quantification of phenotype distribution in (d). Columns represent the mean ± SD, n = 3 of ≥20 cells, ns P > 0.05, **P ≤ 0.01. Unpaired Student’s t-test, two-tailed. Abnormal refers to cells exhibiting multipolar, diffuse bipolar or monopolar mitoses. Scale bars, 10 µm. Source data are provided as a Source Data file
false
Related conjugates and formulations (1)
-
Anti-GABARAPL2/GATE-16 antibody [EP4808] - BSA and Azide free
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (12)
Recent publications for all applications. Explore the full list and refine your search
Nature cell biology 27:1676-1687 PubMed40983659
2025
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in molecular biosciences 12:1578755 PubMed40421419
2025
Applications
Unspecified application
Species
Unspecified reactive species
Journal of cell science 136: PubMed37701987
2023
Applications
Unspecified application
Species
Unspecified reactive species
Cell division 18:9 PubMed37301821
2023
Applications
Unspecified application
Species
Unspecified reactive species
Clinical and translational medicine 12:e958 PubMed35802825
2022
Applications
Unspecified application
Species
Unspecified reactive species
Autophagy 18:2547-2560 PubMed35220892
2022
Applications
Unspecified application
Species
Unspecified reactive species
Cell reports 37:109899 PubMed34706226
2021
Applications
Unspecified application
Species
Unspecified reactive species
Nature communications 10:4176 PubMed31519908
2019
Applications
Unspecified application
Species
Unspecified reactive species
Molecular cell 74:909-921.e6 PubMed31006538
2019
Applications
Unspecified application
Species
Unspecified reactive species
Current biology : CB 29:846-855.e6 PubMed30773365
2019
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com